Nonpsychotropic Cannabinoids, Abnormal Cannabidiol and Canabigerol-Dimethyl Heptyl, Act at Novel Cannabinoid Receptors to Reduce Intraocular Pressure
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonpsychotropic Cannabinoids, Abnormal Cannabidiol and Canabigerol-Dimethyl Heptyl, Act at Novel Cannabinoid Receptors to Reduce Intraocular Pressure
Authors
Keywords
-
Journal
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
Volume 27, Issue 5, Pages 427-435
Publisher
Mary Ann Liebert Inc
Online
2011-07-20
DOI
10.1089/jop.2011.0041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
- (2010) Barbara Bosier et al. BIOCHEMICAL PHARMACOLOGY
- N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
- (2010) Douglas McHugh et al. BMC NEUROSCIENCE
- Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator
- (2010) X Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats
- (2010) Agnieszka Zakrzeska et al. BRITISH JOURNAL OF PHARMACOLOGY
- Physical and functional interaction between CB1cannabinoid receptors and β2-adrenoceptors
- (2010) Brian D Hudson et al. BRITISH JOURNAL OF PHARMACOLOGY
- The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways
- (2009) Heather B Bradshaw et al. BMC BIOCHEMISTRY
- Comparison of Topical and Intravenous Administration of WIN 55-212-2 in Normotensive Rabbits
- (2009) Sandeep S. Samudre et al. CURRENT EYE RESEARCH
- The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation
- (2009) Vincenzo Di Marzo PHARMACOLOGICAL RESEARCH
- 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells
- (2008) Susanne Kreutz et al. GLIA
- Cannabinoid Receptors: Where They are and What They do
- (2008) K. Mackie JOURNAL OF NEUROENDOCRINOLOGY
- Topical WIN55212-2 Alleviates Intraocular Hypertension in Rats Through a CB1 Receptor Mediated Mechanism of Action
- (2008) Matt H. Oltmanns et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Endocannabinoids in the retina: From marijuana to neuroprotection
- (2008) Stephen Yazulla PROGRESS IN RETINAL AND EYE RESEARCH
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells
- (2007) B T McIntosh et al. BRITISH JOURNAL OF PHARMACOLOGY
- GPR55 and the vascular receptors for cannabinoids
- (2007) C R Hiley et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More